Searched for
MEDANTA PROFITABILITY
5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...- Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak SecuritiesIndian hospitals are set for strong revenue growth. Brokerage firm Kotak Securities predicts double-digit gains. EBITDA margins are expecte...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Volatility as opportunity, depends on framework of mind: 5 mid-caps from different sectors with upside potential of up to 31%The Indian stock market is no longer correcting only because of sentiment. It is now adjusting to the possibility of weaker numbers in the ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Time to take the first step to become a contrarian? 4 mid-cap stocks from different sectors with upside potential up to 21%As the risk created by the US-Iran war keeps crude oil prices elevated, the list of stocks where investors can deploy fresh money with comf...
- Medanta expects Noida hospital to turn cash positive within months as expansion drive acceleratesMedanta's new Noida hospital is projected to become cash positive within three to four months, with its startup losses being the primary re...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%In these times of geopolitical stress, how will things pan out for the Indian market? Will it be a standalone underperformer? Or is it just...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...
- Manage short-term risk and volatility for long-term opportunity: 7 stocks from different sectors with upside potential of up to 32%There will be many ifs and buts – and a high volatility quotient – when a market is in its initial phase of correction, especially a correc...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsOver the next few trading sessions, the direction of indices like the Nifty and Sensex will be determined by news on ceasefire violations a...
- Time to be contrarian, but with one condition: 5 mid-cap stocks from different sectors with an upside potential up to 32%Here’s what the street will see in the next couple of days: Discussions on whether the market has bottomed; or if an escalation in the war ...
- Medanta Q3 Results: Profit jumps 15% to Rs 143 crore, revenue rises 12%Global Health (Medanta) reported a 15.6% year-on-year (YoY) jump in net profit to Rs. 143 crore in Q3FY25 due to increase in revenue growth...
- Hospital chain Medanta lines up Rs 1,200 crore for Mumbai entryGlobal Health, operator of Medanta hospitals, is set to build a 500-bed super specialty hospital in Mumbai with an investment of ₹1,200 cro...
- Global Health Q4 Results: Net profit rises 25% to Rs 127 croreFor the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.
- Fundamental Radar: Why Global Health deserves premium valuation vs sector? Sneha Poddar explainsMedanta is a leading tertiary care service provider, with established presence in north and east India. It has built its hospitals network ...
- Medanta sees new hospitals & services, complex specialities boosting marginsMedanta chairman Naresh Trehan said there is a shift in trend from Covid-19 years, as there is less contribution from internal medicine and...
- Medanta's Rs 2,205 crore-IPO to open on November 3The total issue size of the IPO is ₹2,205 crore, which includes a fresh issue of ₹500 crore and an offer for sale (OFS) of up to ₹1,705 cro...
- KKR launches late bid for Trehan’s MedantaKKR swooped down with a late bid after Manipal’s negotiations ran into valuation differences.
- Temasek may buy 18% in Medanta Owner for Rs 700 croreThe Singapore-backed investor is in advanced discussions with Punj Lloyd Ltd, one of the founding promoters of Medanta along with cardiac s...
Load More
